Jan Larmann

researcher

Jan Larmann is …
instance of (P31):
humanQ5

External links are
P227GND ID132167832
P496ORCID iD0000-0003-3365-4572
P1053ResearcherIDB-4034-2011
P214VIAF ID40529083
P10832WorldCat Entities IDE39PBJgtbWdWJwKTMhvcrPgtKd

P108employerUniversity Hospital HeidelbergQ324206
University Hospital MuensterQ1748138
Hannover Medical SchoolQ911561
P735given nameJanQ12173670
JanQ12173670
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q36090800Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition
Q40362800Adrenomedullin Is Associated With Surgical Trauma and Impaired Renal Function in Vascular Surgery Patients
Q41625415Cell-type-specific downregulation of heme oxygenase-1 by lipopolysaccharide via Bach1 in primary human mononuclear cells
Q86497489Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro
Q92068775Elevated Presepsin Is Associated With Perioperative Major Adverse Cardiovascular and Cerebrovascular Complications in Elevated-Risk Patients Undergoing Noncardiac Surgery: The Leukocytes and Cardiovascular Perioperative Events Study
Q90118148Frontline Science: Low regulatory T cells predict perioperative major adverse cardiovascular and cerebrovascular events after noncardiac surgery
Q35874401Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation
Q35757527Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Q80284338High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
Q39669819In vivo fluorescence-mediated tomography for quantification of urokinase receptor-dependent leukocyte trafficking in inflammation.
Q48729033In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
Q46818983Intercellular adhesion molecule-1 inhibition attenuates neurologic and hepatic damage after resuscitation in mice.
Q125100623Intraoperative visualisation of pancreatic leakage (ViP): study protocol for an IDEAL Stage I Post Market Clinical Study
Q34497101Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury
Q48437177Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects.
Q51750226PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells.
Q50716145Perioperative levels and changes of high-sensitivity troponin T are associated with cardiovascular events in vascular surgery patients.
Q95313627Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery
Q96223490Presepsin (sCD14-ST) for pre-operative prediction of major adverse cardiovascular events in coronary heart disease patients undergoing noncardiac surgery: Post hoc analysis of the Leukocytes and Cardiovascular Peri-operative Events-2 (LeukoCAPE-2) S
Q89757904Presepsin as a biomarker in perioperative medicine
Q99596706Prospective evaluation of preoperative lung ultrasound for prediction of perioperative outcome and myocardial injury in adult patients undergoing vascular surgery (LUPPO Study)
Q35392693Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery
Q44691690Risk management for ambulatory anaesthesia
Q112276277Routine Postoperative Antibiotic Prophylaxis Offers No Benefit after Hepatectomy-A Systematic Review and Meta-Analysis
Q44674326Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Q95485374The authors reply
Q45858876Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
Q51751225Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion.
Q37577266Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.
Q114972513Vesseg
Q84396183[The Scientific Working Group, "Young Scientists" of the German Society for Anesthesiology and Intensive Care Medicine]
Q53236305[Tools for junior scientists support from medical societies: survey amongst members organized in the Association of the Scientific Medical Societies (AWMF)].
Q86866056[Tracheostomy techniques]

Search more.